June 2022 Open Meeting

The following items will be on the tentative agenda for the June 16 Commission meeting:

• Policy Statement of the Federal Trade Commission on Rebates and Fees in Exchange for Excluding Lower Cost Drug Products: The Commission will vote on whether to issue a policy statement describing the FTC’s intent to examine rebates and fees paid by drug manufacturers to pharmacy benefit managers and other intermediaries in exchange for disfavoring the lowest cost drug products, including in the case of insulin.
• Report to Congress on Combatting Online Harms through Innovation: FTC staff will provide a presentation and the Commission will vote on whether to issue a report to Congress highlighting current uses of artificial intelligence to combat specific online harms. Some of the harms identified by Congress include scams and fake reviews, deepfakes and dark patterns, hate crimes and harassment, and child sexual abuse. The report also provides high-level policy recommendations.

At the start of the meeting, Chair Khan will offer brief remarks and will then invite members of the public to share feedback on the Commission’s work generally and bring relevant matters to the Commission’s attention. Members of the public must sign up for an opportunity to address the Commission virtually at the June 16 event.